ABVC BioPharma, Inc. (ABVC) financial statements (2022 and earlier)

Company profile

Business Address 44370 OLD WARM SPRINGS BLVD.
FREMONT, CA 94538
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
9/30/2017
9/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,9374,27314440205174
Cash and cash equivalents5,8294,27314440205174
Short-term investments108     
Restricted cash and investments737     
Receivables283696334402,550 
Inventory, net of allowances, customer advances and progress billings26     
Inventory26     
Prepaid expense 172770  
Other undisclosed current assets2,6431,03132316  
Total current assets:9,6256,173878962,755174
Noncurrent Assets
Operating lease, right-of-use asset1,4721,773524
Property, plant and equipment526515521   
Long-term investments and receivables9331,1913,365   
Long-term investments9331,1913,365   
Prepaid expense119119135   
Deposits noncurrent assets     4
Deferred income tax assets9821,791 
Other undisclosed noncurrent assets41461,504   
Total noncurrent assets:4,0735,4346,050  4
TOTAL ASSETS:13,69811,6076,928962,755177
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,3012368544924 
Accounts payable 2324   
Accrued liabilities1,301  5  
Employee-related liabilities  66144424 
Debt1,6401,7362,336300  
Due to related parties393288426250  
Other undisclosed current liabilities3582,7973,3674,569  
Total current liabilities:3,6924,8446,8145,56824 
Noncurrent Liabilities
Long-term debt and lease obligation1,1253,957236   
Long-term debt, excluding current maturities 2,500    
Operating lease, liability1,1251,457236
Liabilities, other than long-term debt   250  
Due to related parties   250  
Other undisclosed noncurrent liabilities(1,114)(1,313)327  
Total noncurrent liabilities:1,1354,100238277  
Other undisclosed liabilities    4,1246,556
Total liabilities:4,8288,9457,0535,8464,1486,556
Stockholders' equity
Stockholders' equity attributable to parent, including:8,8443,438(151)(5,749)(1,393)(6,379)
Common stock292419214214211
Treasury stock, value(9,100)(9,100)(9,100)   
Additional paid in capital58,11440,75228,18013,91513,7894,733
Accumulated other comprehensive income540     
Accumulated deficit(38,481)(25,642)(15,851)(19,878)(15,395)(11,323)
Stockholders' equity note, subscriptions receivable(2,257)(3,160)(4,063)   
Other undisclosed stockholders' equity attributable to parent 565664   
Stockholders' equity attributable to noncontrolling interest27(776)26   
Total stockholders' equity:8,8702,662(125)(5,749)(1,393)(6,379)
TOTAL LIABILITIES AND EQUITY:13,69811,6076,928962,755177

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
9/30/2017
9/30/2016
Revenues356483702   
Loss on disposition of assets for financial service operations(270)(1,169)(210)(2,549)
Cost of revenue(5)(19)(20)(1) (0)
Cost of goods and services sold   (1)  
Gross profit:351464682(1) (0)
Operating expenses(12,057)(8,970)(4,140)(1,394)(3,858)(10,997)
Other undisclosed operating income (loss)   1(138) 
Operating loss:(11,706)(8,506)(3,459)(1,394)(3,996)(10,997)
Nonoperating income (expense)495(2,308)(552)(2,706)(75)(10)
Investment income, nonoperating1355143(0)00
Foreign currency transaction gain (loss), before tax426(3)0  0
Other nonoperating income2217593   
Interest and debt expense(227)(405)(1)(156)(75)(10)
Loss from continuing operations before equity method investments, income taxes:(11,438)(11,219)(4,011)(4,255)(4,146)(11,017)
Other undisclosed income from continuing operations before income taxes22740511567510
Loss from continuing operations before income taxes:(11,211)(10,814)(4,010)(4,099)(4,071)(11,007)
Income tax expense (benefit)(825)22077(2)(1)(1)
Net loss:(12,036)(10,594)(3,933)(4,101)(4,072)(11,008)
Net income attributable to noncontrolling interest12,036     
Other undisclosed net loss attributable to parent(12,036)     
Net loss attributable to parent:(12,036)(10,594)(3,933)(4,101)(4,072)(11,008)
Other undisclosed net loss available to common stockholders, basic(803)     
Net loss available to common stockholders, diluted:(12,839)(10,594)(3,933)(4,101)(4,072)(11,008)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
9/30/2017
9/30/2016
Net loss:(12,036)(10,594)(3,933)(4,101)(4,072)(11,008)
Comprehensive loss:(12,036)(10,594)(3,933)(4,101)(4,072)(11,008)
Comprehensive income, net of tax, attributable to noncontrolling interest12,036     
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(12,864)704299   
Comprehensive loss, net of tax, attributable to parent:(12,864)(9,890)(3,634)(4,101)(4,072)(11,008)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: